Literature DB >> 33268309

Family History of Hypertension, Cardiovascular Disease, or Diabetes and Risk of Developing Preeclampsia: A Systematic Review.

Vanessa R Kay1, Naomi Wedel2, Graeme N Smith2.   

Abstract

Preeclampsia is a severe pregnancy complication with high potential for adverse effects on maternal and fetal health during the perinatal period. It is also associated with an increased risk of maternal cardiovascular disease later in life. Development of preeclampsia can be decreased by prescribing low-dose aspirin to high-risk women. At present, maternal and pregnancy factors are used to assess the risk of preeclampsia. One additional factor that could add to the assessment of risk is a family history of hypertension, cardiovascular disease, or diabetes, especially for nulliparous women who do not have a pregnancy history to inform treatment decisions. Therefore, we conducted a systematic review to assess the association between family history of the aforementioned conditions and preeclampsia. Four databases including MEDLINE, EMBASE, the Cochrane Library, and CINAHL/pre-CINAHL were searched for observational studies that examined a family history of hypertension, cardiovascular disease, or diabetes in women with preeclampsia and in a control population. Studies were evaluated for quality using the Newcastle-Ottawa Scale. A total of 84 relevant studies were identified. A meta-analysis was not conducted due to suspected heterogeneity in the included studies. Most studies reported a positive association between a family history of hypertension or cardiovascular disease and the development of preeclampsia. The majority of studies examining family history of diabetes reported non-significant associations. Overall, family history of hypertension or cardiovascular disease is associated with a higher risk for developing preeclampsia and should be considered when assessing women in the first trimester for low-dose aspirin.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  cardiovascular disease; diabetes mellitus, type 2; hypertension; preeclampsia; risk factors

Mesh:

Substances:

Year:  2020        PMID: 33268309     DOI: 10.1016/j.jogc.2020.08.010

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  4 in total

1.  Seizing the Window of Opportunity Within 1 Year Postpartum: Early Cardiovascular Screening.

Authors:  Christina M Ackerman-Banks; Olga Grechukhina; Erica Spatz; Lisbet Lundsberg; Josephine Chou; Graeme Smith; Victoria R Greenberg; Uma M Reddy; Xiao Xu; Jane O'Bryan; Shelby Smith; Lauren Perley; Heather S Lipkind
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

2.  Risk factors for the development of new-onset and persistent postpartum preeclampsia: A case-control study in Ghana.

Authors:  Linda Ahenkorah Fondjo; Beatrice Amoah; Worlanyo Tashie; John Jude Annan
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

3.  A Prospective Study to Determine the Predictive Ability of HDP-Gestosis Score for the Development of Pre-eclampsia.

Authors:  Meeta Gupta; Poonam Yadav; Farhana Yaqoob
Journal:  J Obstet Gynaecol India       Date:  2022-09-17

4.  The Association of Familial Hypertension and Risk of Gestational Hypertension and Preeclampsia.

Authors:  Małgorzata Lewandowska
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.